- Home
- VGZ vs ONCY Comparison
VGZ vs ONCY Comparison
Compare VGZ & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGZ
- ONCY
- Stock Information
- Founded
- VGZ 1983
- ONCY 1998
- Country
- VGZ United States
- ONCY Canada
- Employees
- VGZ N/A
- ONCY N/A
- Industry
- VGZ
- ONCY Pharmaceuticals and Biotechnology
- Sector
- VGZ
- ONCY Health Care
- Exchange
- VGZ Nasdaq
- ONCY Nasdaq
- Market Cap
- VGZ 127.3M
- ONCY 49.1M
- IPO Year
- VGZ N/A
- ONCY 1999
- Fundamental
- Price
- VGZ $1.00
- ONCY $1.17
- Analyst Decision
- VGZ Strong Buy
- ONCY Strong Buy
- Analyst Count
- VGZ 1
- ONCY 4
- Target Price
- VGZ $2.75
- ONCY $4.33
- AVG Volume (30 Days)
- VGZ 424.2K
- ONCY 1.6M
- Earning Date
- VGZ 07-28-2025
- ONCY 07-31-2025
- Dividend Yield
- VGZ N/A
- ONCY N/A
- EPS Growth
- VGZ N/A
- ONCY N/A
- EPS
- VGZ 0.08
- ONCY N/A
- Revenue
- VGZ N/A
- ONCY N/A
- Revenue This Year
- VGZ N/A
- ONCY N/A
- Revenue Next Year
- VGZ N/A
- ONCY N/A
- P/E Ratio
- VGZ $12.78
- ONCY N/A
- Revenue Growth
- VGZ N/A
- ONCY N/A
- 52 Week Low
- VGZ $0.47
- ONCY $0.33
- 52 Week High
- VGZ $1.30
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- VGZ 47.94
- ONCY 75.27
- Support Level
- VGZ $0.96
- ONCY $0.71
- Resistance Level
- VGZ $1.03
- ONCY $1.31
- Average True Range (ATR)
- VGZ 0.04
- ONCY 0.12
- MACD
- VGZ -0.00
- ONCY 0.04
- Stochastic Oscillator
- VGZ 44.44
- ONCY 81.33
About VGZ Vista Gold Corp
Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.